NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Monday that its third-quarter revenues fell 13 percent year over year as sales from its clinical lab services and products both declined.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.